PharmaCyte Biotech Inc. Common Stock (PMCB)
Stock · NASDAQ · Health Care
$0.515as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$0.683899
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
PharmaCyte Biotech Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PMCBPharmaCyte Biotech Inc. Common Stock$0.515▼ 4.66%Market cap $6.18MP/E —
- BCABBioAtla Inc. Common Stock$1.79▼ 42.99%Market cap $5.41MP/E —$2.81$71.5
- AIMAIM ImmunoTech Inc. Common Stock$0.2558▲ 2.32%Market cap $7.32MP/E —$0.1901$2.89
- PHGEBiomX Inc. COmmon Stock$0.138▲ 4.55%Market cap $4.62MP/E —$0.1192$12.29
- VIVSVivoSim Labs Inc. Common Stock$0.29▲ 0.00%Market cap $4.03MP/E —$0.2625$5.3
- BCDABioCardia Inc. Common Stock$1.16▼ 0.85%Market cap $9.45MP/E —$0.75$2.29
- CRISCuris Inc. Common Stock$1.49▲ 2.76%Market cap $10.04MP/E —$1.4$39
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PMCB PharmaCyte Biotech Inc. Common Stock | $6.18M | — | $0.515 | ▼ 4.66% | |
| BCAB BioAtla Inc. Common Stock | $5.41M | — | $1.79 | ▼ 42.99% | $2.81$71.5 |
| AIM AIM ImmunoTech Inc. Common Stock | $7.32M | — | $0.2558 | ▲ 2.32% | $0.1901$2.89 |
| PHGE BiomX Inc. COmmon Stock | $4.62M | — | $0.138 | ▲ 4.55% | $0.1192$12.29 |
| VIVS VivoSim Labs Inc. Common Stock | $4.03M | — | $0.29 | ▲ 0.00% | $0.2625$5.3 |
| BCDA BioCardia Inc. Common Stock | $9.45M | — | $1.16 | ▼ 0.85% | $0.75$2.29 |
| CRIS Curis Inc. Common Stock | $10.04M | — | $1.49 | ▲ 2.76% | $1.4$39 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 1.10M
- Total value held
- $693.2K
- Institutional holders
- 31
Top holders this quarter
- Unknown519.7K
- Unknown195.7K
- Unknown56.5K
- Unknown52.4K
- Unknown51.5K
- Unknown37.5K
- Unknown35.6K
- Unknown27.0K
- Unknown24.7K
- Unknown22.2K
See the full, filterable feed with live charts on the MarketWall dashboard.